No Love for Accelerated Approval Drugs CMS Announces Valentines Day Model to Decrease Payments for Accelerated Approval Products

The Centers for Medicaid and Medicare Services (CMS) announced a model on February 14, 2023 that would allow CMS to pay less for drugs approved via FDA’s accelerated approval pathway before a clinical benefit has been confirmed by the required confirmatory studies. CMS stated......
By: